189 related articles for article (PubMed ID: 31919934)
1. Genetic risk and atrial fibrillation in patients with heart failure.
Kloosterman M; Santema BT; Roselli C; Nelson CP; Koekemoer A; Romaine SPR; Van Gelder IC; Lam CSP; Artola VA; Lang CC; Ng LL; Metra M; Anker S; Filippatos G; Dickstein K; Ponikowski P; van der Harst P; van der Meer P; van Veldhuisen DJ; Benjamin EJ; Voors AA; Samani NJ; Rienstra M
Eur J Heart Fail; 2020 Mar; 22(3):519-527. PubMed ID: 31919934
[TBL] [Abstract][Full Text] [Related]
2. Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction.
Santema BT; Kloosterman M; Van Gelder IC; Mordi I; Lang CC; Lam CSP; Anker SD; Cleland JG; Dickstein K; Filippatos G; Van der Harst P; Hillege HL; Ter Maaten JM; Metra M; Ng LL; Ponikowski P; Samani NJ; Van Veldhuisen DJ; Zwinderman AH; Zannad F; Damman K; Van der Meer P; Rienstra M; Voors AA
Eur Heart J; 2018 Nov; 39(43):3867-3875. PubMed ID: 30137304
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of atrial fibrillation in acute decompensated heart failure with reduced versus preserved ejection fraction.
Jobs A; Schwind J; Katalinic A; Babaev V; Tilz RR; Rausch S; Thiele H; Eitel I; Eitel C
Clin Res Cardiol; 2019 Jan; 108(1):74-82. PubMed ID: 29987595
[TBL] [Abstract][Full Text] [Related]
4. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
Sartipy U; Dahlström U; Fu M; Lund LH
JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
[TBL] [Abstract][Full Text] [Related]
5. History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure.
Patel RB; Vaduganathan M; Rikhi A; Chakraborty H; Greene SJ; Hernandez AF; Felker GM; Redfield MM; Butler J; Shah SJ
JACC Heart Fail; 2019 Jan; 7(1):47-55. PubMed ID: 30409707
[TBL] [Abstract][Full Text] [Related]
6. Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study.
Saksena S; Slee A; Saad M
J Interv Card Electrophysiol; 2018 Oct; 53(1):9-17. PubMed ID: 29987682
[TBL] [Abstract][Full Text] [Related]
7. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
Slee A; Saad M; Saksena S
J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
[TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
Mentz RJ; Chung MJ; Gheorghiade M; Pang PS; Kwasny MJ; Ambrosy AP; Vaduganathan M; O'Connor CM; Swedberg K; Zannad F; Konstam MA; Maggioni AP
Am Heart J; 2012 Dec; 164(6):884-92.e2. PubMed ID: 23194489
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry.
Zafrir B; Lund LH; Laroche C; Ruschitzka F; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Seferovic PM; Maggioni AP; De Mora Martin M; Polonski L; Silva-Cardoso J; Amir O;
Eur Heart J; 2018 Dec; 39(48):4277-4284. PubMed ID: 30325423
[TBL] [Abstract][Full Text] [Related]
10. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
[TBL] [Abstract][Full Text] [Related]
11. Association of heart rate with mortality in sinus rhythm and atrial fibrillation in heart failure with preserved ejection fraction.
Sartipy U; Savarese G; Dahlström U; Fu M; Lund LH
Eur J Heart Fail; 2019 Apr; 21(4):471-479. PubMed ID: 30698317
[TBL] [Abstract][Full Text] [Related]
12. The association of QRS duration with atrial fibrillation in a heart failure with preserved ejection fraction population: a pilot study.
Gigliotti JN; Sidhu MS; Robert AM; Zipursky JS; Brown JR; Costa SP; Palac RT; Steckman DA; Malenka DJ; Kono AT; Greenberg ML
Clin Cardiol; 2017 Oct; 40(10):861-864. PubMed ID: 28586090
[TBL] [Abstract][Full Text] [Related]
13. A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial.
Piccini JP; Connolly SJ; Abraham WT; Healey JS; Steinberg BA; Al-Khalidi HR; Dignacco P; van Veldhuisen DJ; Sauer WH; White M; Wilton SB; Anand IS; Dufton C; Marshall DA; Aleong RG; Davis GW; Clark RL; Emery LL; Bristow MR
Am Heart J; 2018 May; 199():51-58. PubMed ID: 29754666
[TBL] [Abstract][Full Text] [Related]
14. Atrial Fibrillation Burden and Atrial Shunt Therapy in Heart Failure With Preserved Ejection Fraction.
Patel RB; Reddy VY; Komtebedde J; Wegerich SW; Sekaric J; Swarup V; Walton A; Laurent G; Chetcuti S; Rademann M; Bergmann M; McKenzie S; Bugger H; Bruno RR; Herrmann HC; Nair A; Gupta DK; Lim S; Kapadia S; Gordon R; Vanderheyden M; Noel T; Bailey S; Gertz ZM; Trochu JN; Cutlip DE; Leon MB; Solomon SD; van Veldhuisen DJ; Auricchio A; Shah SJ
JACC Heart Fail; 2023 Oct; 11(10):1351-1362. PubMed ID: 37480877
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
Sobue Y; Watanabe E; Lip GYH; Koshikawa M; Ichikawa T; Kawai M; Harada M; Inamasu J; Ozaki Y
Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492
[TBL] [Abstract][Full Text] [Related]
16. Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status - Report From the Japanese Nationwide Multicenter Registry.
Temma T; Nagai T; Watanabe M; Kamada R; Takahashi Y; Hagiwara H; Koya T; Nakao M; Omote K; Kamiya K; Iwano H; Yamamoto K; Yoshikawa T; Saito Y; Anzai T
Circ J; 2020 Feb; 84(3):397-403. PubMed ID: 32009066
[TBL] [Abstract][Full Text] [Related]
17. Ethnic differences in atrial fibrillation among patients with heart failure in Asia.
Tan ESJ; Goh V; Santema BT; Tay WT; Teng TK; Yap J; Tromp J; Hung CL; Chopra V; Anand I; MacDonald MR; Ling LH; ; Van Gelder IC; Rienstra M; Voors AA; Richards AM; Lam CSP
ESC Heart Fail; 2020 Aug; 7(4):1419-1429. PubMed ID: 32383559
[TBL] [Abstract][Full Text] [Related]
18. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial.
Cikes M; Claggett B; Shah AM; Desai AS; Lewis EF; Shah SJ; Anand IS; O'Meara E; Rouleau JL; Sweitzer NK; Fang JC; Saksena S; Pitt B; Pfeffer MA; Solomon SD
JACC Heart Fail; 2018 Aug; 6(8):689-697. PubMed ID: 30007557
[TBL] [Abstract][Full Text] [Related]
19. Physical Activity, Quality of Life, and Biomarkers in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction (from the NEAT-HFpEF Trial).
Patel RB; Vaduganathan M; Felker GM; Butler J; Redfield MM; Shah SJ
Am J Cardiol; 2019 May; 123(10):1660-1666. PubMed ID: 30876658
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
